Compounds > methylprednisolone

methylprednisolone and piperacillin, tazobactam drug combination

methylprednisolone has been researched along with piperacillin, tazobactam drug combination in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cetinkaya, RA; Coşkun, O; Eyigün, CP; Görenek, L; Ide, T; Kiliç, S; Senses, Z1
Fustini, E; Gennarini, S; Mattioli, M1

Other Studies

2 other study(ies) available for methylprednisolone and piperacillin, tazobactam drug combination

ArticleYear
The effect of methylprednisolone on treatment in rats with induced sepsis.
    Clinical and experimental medicine, 2009, Volume: 9, Issue:1

    Topics: Animals; Disease Models, Animal; Methylprednisolone; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rats; Rats, Sprague-Dawley; Sepsis

2009
Heart transplant recipient patient with COVID-19 treated with tocilizumab.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Cardiomyopathy, Dilated; Cough; COVID-19; COVID-19 Drug Treatment; Diarrhea; Enoxaparin; Enzyme Inhibitors; Exanthema; Fever; Glucocorticoids; Heart Transplantation; Humans; Hydroxychloroquine; Hypoxia; Immunocompromised Host; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Nausea; Piperacillin, Tazobactam Drug Combination; Pulmonary Disease, Chronic Obstructive; Renal Insufficiency, Chronic; SARS-CoV-2; Tachypnea; Treatment Outcome

2020